Home

For Providers

Home

For Providers

Elythea for Payers

Elythea for
Payers

Elythea for Payers

Elythea is a machine learning platform that integrates into the EHR to help predict risk
for pregnancy complications weeks to months in advance of labor and delivery.

By predicting adverse outcomes, we enable doctors to initiate tighter clinical management, give patient-specific counseling, and administer prophylactic medication.

Elythea is a machine learning platform that integrates into the EHR to help predict risk for complications of pregnancy weeks to months in advance of labor and delivery.

By predicting adverse outcomes, we enable doctors to initiate tighter management, give patient-specific counseling, and administer prophylactic medication.

Elythea is a machine learning platform that integrates into the EHR to help predict risk for complications of pregnancy weeks to months in advance of labor and delivery.

By predicting adverse outcomes, we enable doctors to initiate tighter management, give patient-specific counseling, and administer prophylactic medication.

Problem for Payers
OB complications are expensive

Problem

Problem for Payers
OB complications are expensive

Preeclampsia & Eclampsia

Preeclampsia & Eclampsia

The cost to payers per preeclampsia case is $41,790 vs. $13,187 for a healthy delivery 1

Preterm Labor

Preterm Labor

Preterm births cost insurers $76,153; low birthweight infants cost $114,437 2

Preterm births cost insurers $76,153; low birthweight infants

cost $114,437 2

C-Sections & VBAC

C-Sections & VBAC

Average total commercial insurance payment for cesarean is $27,866 vs. $18,329 for vaginal 3

Average commercial insurance payment for cesarean is $27,866 vs. $18,329 for vaginal 3

Postpartum Hemorrhage

Postpartum Hemorrhage

The incremental cost to a California health plan for hemorrhage incidents is $70K/patient 4

The incremental cost to a CA health plan for hemorrhage incidents is $70K/patient 4

1. Hao 2019 2. Beam 2020 3. Chen 2018 4. Ruppel 2021

1. Hao 2019 2. Beam 2020 3. Chen 2018 4. Ruppel 2021

Evidence-based intervention
improves outcomes and reduces costs

Evidence-based intervention
improves outcomes and reduces costs

Evidence-based intervention
improves outcomes and reduces costs

80%
Reduction in preeclampsia
cases with a first-trimester
risk prediction model 5

45%
Reduction of cesarean risk with evidence-based interventions 6

$863
Saved per patient when implementing risk screening for preterm birth 7

68%
Reduction in postpartum hemorrhage cases with earlier intervention 8

5. Park 2021 6. Chen 2018 7. Graber 2021 8. Della Torre 2011

5. Park 2021 6. Chen 2018 7. Graber 2021 8. Della Torre 2011

Elythea
integrates into a disjointed maternal care network, utilizing evidence-driven practices to ensure women get needed care and interventions in advance of and between prenatal visits to minimize adverse outcomes

Our AI Models
outperform existing risk assessments

Our AI Models
outperform existing
risk assessments

Our AI Models
outperform existing risk assessments

Preterm Labor

65%

high-risk sensitivity compared to the 36% of existing cervical length assessments

Postpartum Hemorrhage

3x

higher sensitivity: Elythea flagged 65% of patients as high risk vs. current assessment's 22%

3x

higher sensitivity: Elythea flagged 65% of patients as high risk vs. current assessment's 22%

VBAC

40%

improvement in AUC for predicting successful VBAC

than clinical judgment

40%

improvement in AUC for predicting successful VBAC than clinical judgment

Clinical Validation

Clinical Validation

Tested Models on Every Recorded US Birth Certificate in 2022
Our results exceed currently used risk assessments .

International, multicenter studies testing on 2,000+ women

from 15 sites across Texas, Rhode Island, Cameroon, and Nigeria.

Global, multicenter RCT with 1,500+ women
across 4 African countries to show that hospitals using Elythea have lower complication rates and costs

US RCT With Beth Israel, Harvard Medical School

to conduct a prospective and randomized control trial, pending IRB clearance.

Completed retrospective studies testing our models on all 2021 US births
Our results match or exceed currently
used models.

Prospective, international, multicenter studies testing on 2,000+ women

from 15 sites across Texas, Rhode Island, Cameroon, and Nigeria.

Conducting an international, multicenter RCT with 1,500+ women
across 4 African countries to show that hospitals using Elythea have lower complication rates and associated costs. 

Working with the Beth Israel Deaconess Center of Harvard Medical School
to conduct a prospective and randomized control trial as well, currently pending IRB clearance.

Contact

Elythea 2023